Linda Hellstrom was Appointed as Director, Compliance at Agios Pharmaceuticals

Date of management change: December 20, 2018 

What Happened?

Cambridge, Massachusetts-based Agios Pharmaceuticals Appointed Linda Hellstrom as Director, Compliance


About the Company

Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic disorders of metabolism, which are a subset of orphan genetic metabolic diseases. Metabolism is a complex biological process involving the uptake and assimilation of nutrients in cells to produce energy and facilitate many of the processes required for cellular division and growth. We believe that dysregulation of normal cellular metabolism plays a crucial role in many diseases, including certain cancers and rare diseases. We believe Agios is a first mover in using cellular metabolism, an unexploited area of biological research with disruptive potential, as a platform for developing potentially transformative medicines. We intend to apply our deep understanding of metabolism, coupled with our ability to create medicines that can inhibit or activate metabolic enzymes, to fundamentally change the way cancer and rare genetic disorders of metabolism are treated. We have identified and validated novel and druggable targets in both areas.


About the Person

Linda Hellstrom is Director, Compliance at Agios Pharmaceuticals. Previously, Linda held various senior legal leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Marziotti John, Neumann Christopher, Tang Lauren, Pilkington Lance, Douaihy Toni, Livingston Chris, Hasty Nicole, DiGioia Sheldon Gina, Ackerman Marc, Obitts Timothy, Empie Derek

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.